Please appreciate that there may be other options available to you than the products, providers or services covered by our service. compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. We may also receive compensation if you click on certain links posted on our site. We may receive compensation from our partners for placement of their products or services. While we are independent, the offers that appear on this site are from companies from which receives compensation. and changed its name to RAPT Therapeutics, Inc.į is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. The company was formerly known as FLX Bio, Inc. It is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1 that are in the discovery stage of development. The company's lead inflammation drug candidate is RPT193 to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
Its lead oncology drug candidate is FLX475, an oral small molecule C-C motif chemokine receptor 4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. , a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. This would suggest that RAPT Therapeutics's shares are less volatile than average (for this exchange). The market (NASDAQ average) beta is 1, while RAPT Therapeutics's is 0.1262. A popular way to gauge a stock's volatility is its "beta".īeta is a measure of a share's volatility in relation to the market. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a. Line chart explaining Price target vs Stock Price is described in below table. What this means: Rapt Therapeutics Inc (RAPT) gets an Overall Rank of 59, which is an above average rank under InvestorsObservers stock ranking system. Over the last 12 months, RAPT Therapeutics's shares have ranged in value from as little as $14.89 up to $43.26. UBS Rating and Price Target History Chart. We're not expecting RAPT Therapeutics to pay a dividend over the next 12 months.
Get the latest Rapt Therapeutics RAPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. TTM: trailing 12 months RAPT Therapeutics share dividends View Rapt Therapeutics RAPT investment & stock information. We chose Tradier for this because it offers a wealth of tools and data for active traders, including the ability to use its data and create a custom trading platform. You can search for stocks by company name, and the mobile app is clean and intuitive to use. We chose Robinhood for this category because it offers commission-free trading and is easy to use. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
We chose SoFi for this category because it offers a free robo-advisor as well as commission-free stocks. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.
Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs.
Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions. As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels. In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance. Technical Analysis refers to analyzing a stock's price over a period of time.